10-K Decoder · All companies

Dyne Therapeutics, Inc.

DYN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$468M−$344M−36.1%
Net income−$446M−$317M−40.6%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$197M−$114M−73.0%
Net income−$194M−$108M−79.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Dyne Therapeutics's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Dyne Therapeutics profitable in FY2025?
No: net income was −$446M and operating income −$468M in FY2025.
What was Dyne Therapeutics's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 5, 2026.